Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion type Assertion NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_head.
- NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion wasGeneratedBy ECO_0000203 NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_provenance.
- NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion wasDerivedFrom befree-2016 NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_provenance.
- NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion SIO_000772 22123186 NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_provenance.
- NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion evidence source_evidence_literature NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_provenance.
- NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_assertion description "[Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP942330.RABKiRPpHEQG6txnSgvu_yVyG7KeGY9qUl_qsRTOxeNeQ130_provenance.